About Prenosis
Prenosis is a biology-based technology company focused on redefining the standard of care for critical conditions through integrated diagnostics and therapeutics. The company’s core mission is to tailor healthcare to each patient’s unique biology by leveraging deep data and artificial intelligence (AI). Their flagship product, Sepsis ImmunoScore®, is the first FDA-authorized AI diagnostic tool for sepsis, designed to assist providers in identifying patients at risk for sepsis or its progression within 24 hours. This tool integrates up to 22 parameters, including lab biomarkers, vital signs, and demographics, to provide an individualized risk assessment and stratify patients into four discrete risk groups.
For physicians, Prenosis’s technology aims to augment clinical decision-making by providing real-time, transparent insights into a patient’s biological status. The Sepsis ImmunoScore® integrates directly into hospital Electronic Medical Record (EMR) systems, presenting an intuitive display that reveals how individual patient parameters contribute to their risk score, fostering trust and a clinician-AI partnership. Beyond sepsis, Prenosis is expanding its precision medicine platform, Immunix™, to address other critical care conditions such as pneumonia, acute heart failure (AHF), acute respiratory distress syndrome (ARDS), and acute kidney injury (AKI). The company’s approach emphasizes moving beyond one-size-fits-all protocols to deliver personalized care, ultimately aiming to improve patient outcomes and reduce hospital costs.
What Physicians Need to Know
For physicians, Prenosis' Sepsis ImmunoScore offers a powerful tool for earlier and more accurate sepsis diagnosis and risk assessment. It analyzes up to 22 diverse parameters from a patient's Electronic Health Record (EHR), including biomarkers and clinical data, to generate a risk score and assign patients to one of four discrete risk categories. This tool not only aids in diagnosing sepsis but also predicts critical outcomes such as in-hospital mortality, length of stay, ICU admission, mechanical ventilation, and vasopressor use within 24 hours. The Sepsis ImmunoScore is designed for seamless integration into existing hospital EHR/EMR systems and provides a transparent display explaining how each parameter contributed to the final score, fostering trust and a true clinician-AI partnership. This allows for more personalized treatment decisions, potentially leading to improved patient outcomes, reduced hospital costs, and better compliance with quality metrics like the SEP-1 bundle.
The Sepsis ImmunoScore is designed for direct integration into hospital Electronic Health Records (EHRs) and Electronic Medical Records (EMRs). It has the potential to utilize FHIR backend platforms for data integration. Prenosis has also partnered with Roche for the commercial distribution of the Sepsis ImmunoScore, making it available on Roche's navify Algorithm Suite.
What the Web Says
Prenosis is a company that has developed the Sepsis ImmunoScore, an AI-powered diagnostic tool for early sepsis detection and prediction of patient outcomes. The Sepsis ImmunoScore was authorized by the FDA in 2024, making it the first AI diagnostic test for sepsis. The tool analyzes 22 health metrics to provide a sepsis risk score and predict the likelihood of severe cases within 24 hours. While the product has received positive attention for its innovative approach to sepsis diagnosis, there is limited accessible review coverage for Prenosis on traditional software review platforms like G2, Capterra, and TrustRadius.
Overall: MixedStrengths
- FDA-authorized AI diagnostic tool for sepsis, the first of its kind.
- Utilizes AI to analyze 22 health metrics for early sepsis detection and outcome prediction.
- Aims to reduce antibiotic overprescription and improve identification of SEP-1 bundle non-compliance cases.
- Recognized by TIME magazine as one of the best inventions of 2024 for saving crucial time in medical care.
- Designed to augment clinician decision-making rather than replace it.
- Potential to transform sepsis management by providing trustworthy predictive information for a proactive approach to care.
Limitations
- Limited accessible review coverage on traditional software review platforms (G2, Capterra, TrustRadius).
- Potential limitations if required lab biomarkers are not available or cannot be operationalized with suitable turnaround time.
- May face challenges if organizations are tightly constrained to EHR-native workflows and cannot integrate a separate Software as a Medical Device (SaMD).
- Publicly available materials do not clearly document SOC 2/ISO certifications, which may be a barrier for some procurement processes.
- Some employee reviews for companies with similar names (e.g., Prenuvo, Prominis, ProNexis) mention issues with work-life balance, management, and pay, though these are not confirmed to be for Prenosis.
Based on reviews from: G2.com, Substack.com, cmrubinworld.com, Time.com, Beckershospitalreview.com, Prenosis.com, Healthcarenowradio.com, Simplyhired.com, Proximacro.com, Indeed.com, Softwareadvice.com, Healthcareittoday.com, Airframe.ai, Bizjournals.com, Lensa.com, Capterra.com, Reddit.com, Cablesandkits.com, Jobtoday.com
Last updated: 2026-10-29
Videos
News, demos, and interviews about Prenosis.
Videos load interactively. If none appear, search YouTube for Prenosis →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Prenosis.
Comparisons
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]